OTC Markets OTCPK - Delayed Quote USD
Aptose Biosciences Inc. (APTOF)
2.3100
-0.1600
(-6.48%)
At close: April 22 at 4:00:00 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| RICE WILLIAM GLENN Chief Executive Officer | Purchase | Nov 25, 2024 | 613,252 |
| SEIZINGER BERND R. Director | Purchase | Sep 22, 2023 | 17,000 |
Related Tickers
CLVLY Clinuvel Pharmaceuticals Limited
7.10
0.00%
BINV.ST BioInvent International AB (publ)
29.15
+3.37%
ACTU Actuate Therapeutics, Inc. Common stock
8.52
+1.79%
WHWK Whitehawk Therapeutics, Inc.
1.5400
-0.65%
EXOZ eXoZymes, Inc.
11.79
+9.67%
CUE Cue Biopharma, Inc.
0.7827
+0.19%
SANION.ST Saniona AB (publ)
7.16
+6.87%
THAR Tharimmune, Inc.
1.1697
-2.53%
TENX Tenax Therapeutics, Inc.
5.10
-0.78%
TYRA Tyra Biosciences, Inc.
9.47
+4.53%